PATENT CLAIM ANALYSIS

Application Number: 16016165
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "021900"]

Abstract:
The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.

Claim (Index 4):
A pharmaceutical composition comprising a peptide salt wherein the peptide has a sequence selected from SEQ ID NOs: 1-16 and the salt is selected from the group consisting of maleate, hydrochloride, and lactate.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14056496', '13265918', '13387051', '13133288', '13508648']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7465679778641059
- 35 USC 102 Novelty (BERT): 0.5761488924967554
- Combined Prediction Score: 0.7295260693273709
- Mean Citation Score: 273.109084
- Max Citation Score: 525.0237
- Similarity Product: 365.9656291850209

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test